Death rate higher in patients who are given aprotinin
Patients Who Used Aprotinin In Heart Surgery Are At Risk Of Dying. Patients who are given a widely used drug to prevent excessive bleeding during heart surgery are at increased risk of dying within five years following their operations, medical researchers have found in the largest study of its kind. Results from an international … [Read more...]
Bayer’s Heart-Surgery Drug Increases Risk of Death
Controversial Heart-Surgery Drug Aprotinin Is Under Fire. Bayer’s controversial heart-surgery drug aprotinin, marketed as Trasylol, is under fire yet again thanks to a new study that found that the drug carries with it an increased risk of long-term mortality. Trasylol is a widely used drug intended to reduce bleeding during … [Read more...]
